These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 25603171)

  • 21. The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor.
    Johns TG; Mellman I; Cartwright GA; Ritter G; Old LJ; Burgess AW; Scott AM
    FASEB J; 2005 May; 19(7):780-2. PubMed ID: 15774576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probing homodimer formation of epidermal growth factor receptor by selective crosslinking.
    Sun X; Dusserre-Bresson F; Baker B; Zhang A; Xu P; Fibbe C; Noren CJ; Corrêa IR; Xu MQ
    Eur J Med Chem; 2014 Dec; 88():34-41. PubMed ID: 25042004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand-induced structural transitions in ErbB receptor extracellular domains.
    Dawson JP; Bu Z; Lemmon MA
    Structure; 2007 Aug; 15(8):942-54. PubMed ID: 17697999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High affinity nanobodies against human epidermal growth factor receptor selected on cells by E. coli display.
    Salema V; Mañas C; Cerdán L; Piñero-Lambea C; Marín E; Roovers RC; Van Bergen En Henegouwen PM; Fernández LÁ
    MAbs; 2016 Oct; 8(7):1286-1301. PubMed ID: 27472381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycosylation promotes the cancer regulator EGFR-ErbB2 heterodimer formation - molecular dynamics study.
    Motamedi Z; Rajabi-Maham H; Azimzadeh Irani M
    J Mol Model; 2021 Nov; 27(12):361. PubMed ID: 34817689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spatial structure of the transmembrane domain heterodimer of ErbB1 and ErbB2 receptor tyrosine kinases.
    Mineev KS; Bocharov EV; Pustovalova YE; Bocharova OV; Chupin VV; Arseniev AS
    J Mol Biol; 2010 Jul; 400(2):231-43. PubMed ID: 20471394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions.
    Wehrman TS; Raab WJ; Casipit CL; Doyonnas R; Pomerantz JH; Blau HM
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19063-8. PubMed ID: 17148612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function.
    Mattoon D; Klein P; Lemmon MA; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):923-8. PubMed ID: 14732693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosteric regulation of epidermal growth factor (EGF) receptor ligand binding by tyrosine kinase inhibitors.
    Macdonald-Obermann JL; Pike LJ
    J Biol Chem; 2018 Aug; 293(35):13401-13414. PubMed ID: 29997256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A structure-based model for ligand binding and dimerization of EGF receptors.
    Klein P; Mattoon D; Lemmon MA; Schlessinger J
    Proc Natl Acad Sci U S A; 2004 Jan; 101(4):929-34. PubMed ID: 14732694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescently tagged nanobodies and NanoBRET to study ligand-binding and agonist-induced conformational changes of full-length EGFR expressed in living cells.
    Comez D; Glenn J; Anbuhl SM; Heukers R; Smit MJ; Hill SJ; Kilpatrick LE
    Front Immunol; 2022; 13():1006718. PubMed ID: 36505413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.
    Roovers RC; Laeremans T; Huang L; De Taeye S; Verkleij AJ; Revets H; de Haard HJ; van Bergen en Henegouwen PM
    Cancer Immunol Immunother; 2007 Mar; 56(3):303-317. PubMed ID: 16738850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation and characterization of humanized nanobodies targeting the dimer interface of epidermal growth factor receptor (EGFR).
    Zhu H; Zhao L; Li Z; Wen B; Qiu C; Liu M; Xu Z; Hu S; Li H
    Protein Expr Purif; 2019 May; 157():57-62. PubMed ID: 30735705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.
    Dawson JP; Berger MB; Lin CC; Schlessinger J; Lemmon MA; Ferguson KM
    Mol Cell Biol; 2005 Sep; 25(17):7734-42. PubMed ID: 16107719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. On the nature of low- and high-affinity EGF receptors on living cells.
    Ozcan F; Klein P; Lemmon MA; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5735-40. PubMed ID: 16571657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.
    Johannessen LE; Haugen KE; østvold AC; Stang E; Madshus IH
    Biochem J; 2001 May; 356(Pt 1):87-96. PubMed ID: 11336639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.